ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharma biotech biobusiness industry

The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016 | 7 min read
The state’s industry draws inspiration from medicine as well as agriculture.
Photo of lab-grown chicken from Eat Just, Inc.
Cultured Meat Advances Toward the Market
Abby Olena, PhD | Feb 14, 2022 | 8 min read
The biotech industry is chipping away at the obstacles standing between the lab and the dinner plate.
Incubator Boom
Kerry Grens | Mar 1, 2014 | 7 min read
From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?
 
How the Pharma Industry Pulled Off the Pivot to COVID-19
Diana Kwon | Jul 13, 2020 | 9 min read
The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.
computing a cure
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019 | 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Pharma’s Ghost Labs Find New Life
Katarina Zimmer | Nov 1, 2019 | 9 min read
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
small-molecule therapeutics treat cancer and other diseases
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Claire Asher | Apr 1, 2019 | 9 min read
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
Pharma Looks to Outer Space to Boost Drug R&D
Katarina Zimmer | Dec 1, 2020 | 9 min read
There are benefits of studying certain biological processes under microgravity, but whether those advantages outweigh the costs of getting experiments off Earth remains to be seen.
type 1 diabetes
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Eric Bender | Jul 15, 2019 | 8 min read
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
Another CAR-T IPO
Jef Akst | Apr 6, 2015 | 1 min read
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.

Run a Search

ADVERTISEMENT